急性髓性白血病中的长非编码RNA:生物标志物,预后指标和治疗潜力
Maryam Farajzadeh1,2, Mehrdad Fathi1,2, Pooya Jalali3
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Cancer cell international
|April 5, 2025
概括
长非编码RNAs (lncRNAs) 是急性髓性白血病 (AML) 发展和进展的关键参与者. 这次审查强调了lncRNAs作为AML诊断,预后和治疗策略的有前途的生物标志物.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 是关键的基因表达调节器,参与生物功能.
- lncRNAs越来越多地被认为是急性髓性白血病 (AML) 的失调,影响疾病的发病和进展.
研究的目的:
- 审查lncRNAs在急性髓性白血病 (AML) 中的关键作用.
- 突出 lncRNAs作为潜在的预后生物标志物和AML的治疗点.
主要方法:
- 关于AML中的lncRNAs最近研究的文献综述.
- 分析lncRNA参与AML病变,诊断和治疗耐药性的情况.
主要成果:
- lncRNAs在AML中失调,并有助于其发展和进展.
- 一个 lncRNAs 的子集显示出作为 AML 的诊断和预后生物标志物的潜力.
- lncRNAs与AML的耐药性有关.
结论:
- lncRNAs在AML中具有重要作用,影响疾病进展和治疗结果.
- lncRNAs代表了AML诊断,预后和治疗向的有希望的新型标记物.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.3K
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
